Submitted by reuters8361 in news
Eli Lilly and Co <a href="https://www.reuters.com/markets/companies/LLY.N" target="_blank">(LLY.N)</a> said on Thursday that the U.S. health regulator had approved its drug for treating adults with moderate-to-severe active ulcerative colitis, a type of chron…